Daily coffee habit slashes dementia risk - but you have to do it right
Share this @internewscast.com

An extensive study following over 130,000 individuals over 40 years has identified a correlation between regular caffeine intake and a reduction in dementia risk.

Conducted by Harvard researchers, the study discovered that those who consumed the most coffee experienced an 18% lower likelihood of developing dementia compared to those who seldom drank it.

Similarly, avid tea drinkers at the highest consumption levels enjoyed a 16% decrease in their dementia risk.

This protective effect is attributed to caffeine’s ability to combat inflammation and prevent the accumulation of detrimental proteins in the brain, which are factors known to contribute to cognitive decline.

Decaf fails to deliver

However, those seeking benefits from decaffeinated versions will be let down, as the study found no protective advantages from caffeine-free coffee or tea.

This finding affirms that caffeine itself is responsible for the protective effects, rather than other components in these beverages.

Healthcare workers formed the basis of the investigation, with scientists monitoring their intake of caffeinated products from coffee, tea, fizzy drinks and chocolate.

Beyond just lowering disease risk, higher caffeine consumption correlated with better overall brain performance and slower rates of cognitive decline.

Moderation proves optimal

The research revealed an unexpected twist – moderate consumption produced the strongest protective effects, with no extra gains for people drinking larger quantities.

Lead researcher Yu Zhang, a Harvard Chan School PhD student, explained: “Caffeine is likely equally beneficial for people with high and low genetic risk of developing dementia.”

Senior researcher Dr Daniel Wang from Mass General Brigham’s Department of Medicine noted: “While our results are encouraging, it’s important to remember that the effect size is small and there are lots of important ways to protect cognitive function as we age.”

Study limitations acknowledged

Dementia developed in 11,033 people during the 43-year tracking period.

Professor Tara Spires-Jones from the UK Dementia Research Institute, who did not participate in the research, cautioned:

“This kind of observational research cannot prove conclusively that caffeine intake was the reason for lower dementia risk.”

Share this @internewscast.com
You May Also Like

Urgent NHS Alert: Recognize These 4 Symptoms That Require Immediate 999 Call

The National Health Service (NHS) is making an urgent appeal for individuals…

Surprising Study Reveals Smoking’s Unexpected Link to Reduced Dementia Risk Among 18 Million Americans

Researchers in Colorado have put forth intriguing findings suggesting that cannabis, when…

Scientists Debunk Breakfast Myths: Why You Can Stop Worrying About Cholesterol

Some people have been worried about how eggs could lead to increases…

Rare Illness Unveiled: 11-Year-Old Girl’s Persistent Sickness Leads to Surprising Diagnosis in the UK

Millie Butler with her dad Conal (Image: Conal Butler/SWNS) An 11-year-old schoolgirl…

Unmasking the Hidden Cause of Hair Loss: How a Common Mineral Deficiency Fooled a Mother-of-Two

Overwhelmed by persistent fatigue, weakness, and severe hair loss, Rose Stokes feared…

This Morning’s Gyles Brandreth Sheds 5lbs in 2 Weeks with One Easy Breakfast Routine

This Morning’s Gyles Brandreth has unveiled an unexpected method for shedding 5…

Scientists Explore Potential of Fat Injection to Treat Unexpected Health Condition

Liz Formby MBE, a retired civil servant celebrated in the Queen’s Birthday…

BBC Morning Live Doctor Suggests Tesco Clubcard Data Could Aid in Early Cancer Detection

Scientists are analysing shopping data to identify early signs of 10 different…

Boost Brain Health: Reading, Writing, and Language Learning Reduce Alzheimer’s Risk by 40%

Engaging in activities such as reading, writing, or learning a new language…

James Van Der Beek Reveals Overlooked Early Symptoms of Bowel Cancer: Expert Tips on Risk Reduction

The recent death of James Van Der Beek serves as a poignant…

NIH Explores Innovative Use of Covid Drug in Cancer Treatment Trials

The debate surrounding ivermectin, a drug initially known for treating parasitic infections…